PBI vertical.jpg
Ironridge BioPharma to Invest $500,000 in Pressure BioSciences
April 09, 2012 08:15 ET | Pressure BioSciences, Inc.
SOUTH EASTON, Mass., April 9, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company") today announced that it has entered into a definitive agreement with Ironridge...
PBI vertical.jpg
Pressure BioSciences Common Stock to Begin Trading Today on the OTCQB(TM) Tier of the OTC Marketplace
April 05, 2012 09:59 ET | Pressure BioSciences, Inc.
SOUTH EASTON, Mass., April 5, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that its common stock will begin trading on the OTCQB tier of...
PBI vertical.jpg
Pressure BioSciences and Sage-N Research to Collaborate on Improving the Extraction and Analysis of Integral Cell Membrane Proteins That May be Associated With Cancer, Stroke, and Other Diseases and Disorders
March 19, 2012 10:35 ET | Pressure BioSciences, Inc.
SOUTH EASTON, Mass. and MILPITAS, Calif., March 19, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" and the "Company"), a leading sample preparation tools company for the...
PBI vertical.jpg
Dr. Henry C. Lee, One of the World's Leading Forensic Scientists, to Investigate the Use of Pressure BioSciences' Enabling Pressure Cycling Technology ("PCT") Platform for Use in Multiple Areas of Forensic Analysis
March 09, 2012 07:31 ET | Pressure BioSciences, Inc.
SOUTH EASTON, Mass., March 9, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" or the "Company") today announced that it has entered into a collaboration with the Henry C. Lee...
PBI vertical.jpg
NASDAQ Panel Grants Pressure BioSciences' Request for Continued Listing Pursuant to an Extension
March 08, 2012 09:34 ET | Pressure BioSciences, Inc.
SOUTH EASTON, Mass., March 8, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" or the "Company") today announced that on March 7, 2012, the Company received notice that the...
PBI vertical.jpg
New Data Indicate Pressure BioSciences' Novel Technology Platform Offers Great Promise to the Areas of Biomarker Discovery and Drug Development
March 07, 2012 09:47 ET | Pressure BioSciences, Inc.
SOUTH EASTON, Mass., March 7, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" and the "Company") today announced that data supporting important advantages of PBI's powerful...
PBI vertical.jpg
Pressure BioSciences, Inc. Continues Expansion of European Sales Reach With Distribution Agreement for the Benelux Countries
March 01, 2012 09:29 ET | Pressure BioSciences, Inc.
SOUTH EASTON, Mass., March 1, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" or the "Company") today announced that it has entered into a distribution agreement with...
PBI vertical.jpg
Pressure BioSciences, Inc. to Discuss Fourth Quarter and FY2011 Financial Results and Provide Business Update
February 29, 2012 13:56 ET | Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Feb. 29, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) today announced that the Company will host a teleconference to discuss its Q4 and FY2011 financial...
PBI vertical.jpg
Pressure BioSciences, Inc. Reports 2011 Financial Results
February 28, 2012 12:47 ET | Pressure BioSciences, Inc.
Revenue Up 66% in Second Half Over First Half; Pace of Consumables Sales Increased Significantly in Second Half 2011 SOUTH EASTON, Mass., Feb. 28, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences,...
PBI vertical.jpg
Pressure BioSciences, Inc. Closes $800,000 Private Placement
February 08, 2012 10:06 ET | Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Feb. 8, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" or the "Company") today announced that it has closed on an $800,000 private placement with the...